Robert Pierce
2021 - Sensei Biotherapeutics
In 2021, Robert Pierce earned a total compensation of $2.3M as Former Chief R&D Officer at Sensei Biotherapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $167,700 |
|---|---|
| Option Awards | $1,620,922 |
| Salary | $410,000 |
| Other | $62,791 |
| Total | $2,261,413 |
Pierce received $1.6M in option awards, accounting for 72% of the total pay in 2021.
Pierce also received $167.7K in non-equity incentive plan, $410K in salary and $62.8K in other compensation.
Rankings
In 2021, Robert Pierce's compensation ranked 5,557th out of 12,406 executives tracked by ExecPay. In other words, Pierce earned more than 55.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,557 out of 12,406 | 55th |
Division Manufacturing | 2,349 out of 5,494 | 57th |
Major group Chemicals And Allied Products | 1,020 out of 2,369 | 57th |
Industry group Drugs | 909 out of 2,090 | 57th |
Industry Pharmaceutical Preparations | 654 out of 1,537 | 57th |
Source: SEC filing on June 15, 2023.
Pierce's colleagues
We found two more compensation records of executives who worked with Robert Pierce at Sensei Biotherapeutics in 2021.